Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

THA1 Inhibitors

Chemical inhibitors of THA1 target various kinases involved in the regulation of the cell cycle, particularly the mitotic phase, where THA1 plays a crucial role. ZM-447439, VX-680 (Tozasertib), MLN8237, Alisertib, Barasertib, AZD1152-HQPA, Hesperadin, Danusertib, AT9283, GSK1070916, SNS-314, and CCT137690 each possess the ability to disrupt the normal function of THA1 indirectly through their action on Aurora kinases, which are integral to cell division. For instance, ZM-447439 and VX-680 both inhibit Aurora kinases, resulting in the disruption of chromosome alignment and segregation, processes that are essential for accurate cell division and where THA1 is known to be active. By impeding these kinases, these inhibitors can lead to the functional inhibition of THA1 by preventing it from fulfilling its role in the mitotic checkpoint signaling.

Furthermore, MLN8237 and its structural analog Alisertib specifically inhibit Aurora A kinase, one of the key enzymes that facilitate the entry into mitosis. The inhibition of this kinase can impede the cell cycle at a point where THA1 is functionally relevant. Similarly, Barasertib and AZD1152-HQPA, by targeting Aurora B kinase, can obstruct cytokinesis and the mitotic checkpoint, thereby indirectly inhibiting THA1. Hesperadin and Danusertib extend these effects to disrupt not only Aurora B but also Aurora A kinases, leading to a broader disruption of the cell cycle and mitotic events. AT9283's ability to inhibit several kinases, including Aurora kinases, JAK2, and Abl, further supports the notion that the inhibition of these kinases can lead to the indirect inhibition of THA1 by blocking the cell cycle progression. Moreover, GSK1070916's inhibition of Aurora B/C kinases, SNS-314's selective inhibition of Aurora kinases, and CCT137690's inhibition of Aurora kinases A and B represent additional strategies by which the normal function of THA1 during cell division can be indirectly inhibited, emphasizing the key role of these kinases in the cellular processes that THA1 is involved in.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

Inhibits THA1 by targeting Aurora kinases, which are crucial for proper chromosome alignment and segregation during mitosis. By disrupting these processes, ZM-447439 indirectly inhibits THA1's function in mitotic checkpoint signaling.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$62.00
$87.00
4
(1)

Inhibits THA1 indirectly by targeting Aurora kinases which are involved in the regulation of mitosis. Inhibition of these kinases disrupts cell cycle progression and can lead to the functional inhibition of THA1.

MLN8237

1028486-01-2sc-394162
5 mg
$220.00
(0)

Specifically inhibits Aurora A kinase, which is involved in the cell cycle, particularly in the entry into mitosis. By inhibiting this kinase, MLN8237 can indirectly inhibit THA1 by disrupting the cell cycle and thus THA1's role in it.

AZD1152-HQPA

722544-51-6sc-265334
10 mg
$375.00
(0)

By inhibiting Aurora B kinase, AZD1152-HQPA indirectly inhibits THA1 by interfering with the normal function of the mitotic checkpoint, a cellular process that THA1 regulates.

Hesperadin

422513-13-1sc-490384
10 mg
$304.00
(0)

Inhibits Aurora B kinase, leading to an indirect inhibition of THA1 function in chromosome alignment and segregation during mitosis.

CCT 137690

1095382-05-0sc-362722
sc-362722A
10 mg
50 mg
$225.00
$945.00
(0)

Inhibits Aurora kinases A and B, subsequently disrupting mitosis and indirectly inhibiting THA1 by affecting its role in the mitotic checkpoint and chromosome segregation.